Literature DB >> 16281943

Circulating CD10-/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil release.

Y Orr1, J M Taylor, P G Bannon, C Geczy, L Kritharides.   

Abstract

Circulating neutrophil phenotype and function are altered during neutrophilia associated with acute inflammatory states, however, the contribution of bone marrow neutrophil release to these changes has been difficult to quantify in humans. Accelerated release of neutrophils, with potentially distinct attributes, from the bone marrow and their dilution within the circulating pool may produce these apparent changes. Unfortunately selective analysis of these newly emergent neutrophils is difficult given their morphologic similarity to those already in the circulation and the coincident effect of soluble inflammatory mediators on circulating neutrophil phenotype and function. Using whole blood flow cytometry and cardiac surgery as an inflammatory stimulus, we demonstrate the emergence of a unique subpopulation of circulating neutrophils characterised as CD10(-)/CD16(low), indicative of active bone marrow neutrophil release peri-operatively. CD10(-)/CD16(low) neutrophils emerge at the same operative stages as band forms and a left shift, yet represent over 40% of circulating neutrophils postoperatively, and generate a greater stimulus-induced [Ca(2+)](i) flux than their CD10(+) counterparts. We conclude that CD10(-)/CD16(low) neutrophils represent a significant proportion of the circulating pool after cardiac surgery and that bone marrow release, a major contributor to neutrophilia, influences the phenotype and functional activity of circulating neutrophils following this acute inflammatory stimulus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16281943     DOI: 10.1111/j.1365-2141.2005.05794.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy.

Authors:  Jana Blazkova; Sarthak Gupta; Yudong Liu; Brice Gaudilliere; Edward A Ganio; Christopher R Bolen; Ron Saar-Dover; Gabriela K Fragiadakis; Martin S Angst; Sarfaraz Hasni; Nima Aghaeepour; David Stevenson; Nicole Baldwin; Esperanza Anguiano; Damien Chaussabel; Matthew C Altman; Mariana J Kaplan; Mark M Davis; David Furman
Journal:  J Immunol       Date:  2017-02-08       Impact factor: 5.422

2.  A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score.

Authors:  Jan-Alexis Tremblay; Florian Peron; Louis Kreitmann; Julien Textoris; Karen Brengel-Pesce; Anne-Claire Lukaszewicz; Laurence Quemeneur; Christophe Vedrine; Lionel K Tan; Fabienne Venet; Thomas Rimmele; Guillaume Monneret
Journal:  Ann Intensive Care       Date:  2022-08-17       Impact factor: 10.318

3.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

4.  Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression.

Authors:  Birgit Sawitzki; Claudio Brunstein; Christian Meisel; Julia Schumann; Katrin Vogt; Christine Appelt; Julie M Curtsinger; Michael R Verneris; Jeffrey S Miller; John E Wagner; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-01       Impact factor: 5.742

5.  Low-density neutrophils in chronic graft versus host disease (cGVHD) are primarily immature CD10- and enhance T cell activation.

Authors:  Nick C Matthews; Charlotte S Burton; Arun Alfred
Journal:  Clin Exp Immunol       Date:  2021-05-31       Impact factor: 5.732

6.  Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus.

Authors:  Anders A Bengtsson; Åsa Pettersson; Stina Wichert; Birgitta Gullstrand; Markus Hansson; Thomas Hellmark; Åsa C M Johansson
Journal:  Arthritis Res Ther       Date:  2014-06-05       Impact factor: 5.156

7.  Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).

Authors:  Christine M Freeman; Sean Crudgington; Valerie R Stolberg; Jeanette P Brown; Joanne Sonstein; Neil E Alexis; Claire M Doerschuk; Patricia V Basta; Elizabeth E Carretta; David J Couper; Annette T Hastie; Robert J Kaner; Wanda K O'Neal; Robert Paine; Stephen I Rennard; Daichi Shimbo; Prescott G Woodruff; Michelle Zeidler; Jeffrey L Curtis
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

8.  Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.

Authors:  Åsa Cm Johansson; Sophie Ohlsson; Åsa Pettersson; Anders A Bengtsson; Daina Selga; Markus Hansson; Thomas Hellmark
Journal:  Arthritis Res Ther       Date:  2016-04-22       Impact factor: 5.156

9.  Antibodies in Melioidosis: The Role of the Indirect Hemagglutination Assay in Evaluating Patients and Exposed Populations.

Authors:  Panjaporn Chaichana; Kemajittra Jenjaroen; Premjit Amornchai; Suchintana Chumseng; Sayan Langla; Patpong Rongkard; Manutsanun Sumonwiriya; Atthanee Jeeyapant; Narisara Chantratita; Prapit Teparrukkul; Direk Limmathurotsakul; Nicholas P J Day; Vanaporn Wuthiekanun; Susanna J Dunachie
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

10.  Multi-dimensional flow cytometry analysis reveals increasing changes in the systemic neutrophil compartment during seven consecutive days of endurance exercise.

Authors:  Selma van Staveren; Twan Ten Haaf; Margot Klöpping; Bart Hilvering; Gerjen H Tinnevelt; Karin de Ruiter; Maria F Piacentini; Bart Roelands; Romain Meeusen; Jos J de Koning; Jeroen J Jansen; Nienke Vrisekoop; Leo Koenderman
Journal:  PLoS One       Date:  2018-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.